Literature DB >> 27664266

The Brief Case: Dyspnea in a Profoundly Immunocompromised Man.

Andrej Spec1, Carlos A Q Santos1, Morgan A Pence2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27664266      PMCID： PMC5035409          DOI： 10.1128/JCM.00049-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.

Authors:  Georgios Chamilos; Dimitrios P Kontoyiannis
Journal:  J Infect       Date:  2005-11       Impact factor: 6.072

Review 2.  Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections.

Authors:  F J Pastor; J Guarro
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

3.  Identification of Paecilomyces variotii in clinical samples and settings.

Authors:  Jos Houbraken; Paul E Verweij; Anthonius J M M Rijs; Andrew M Borman; Robert A Samson
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

4.  Paecilomyces variotii as an Emergent Pathogenic Agent of Pneumonia.

Authors:  Bruna Steiner; Valerio R Aquino; Alessandra A Paz; Lucia Mariano da Rocha Silla; Alexandre Zavascki; Luciano Z Goldani
Journal:  Case Rep Infect Dis       Date:  2013-05-30

5.  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

Authors:  A M Tortorano; M Richardson; E Roilides; A van Diepeningen; M Caira; P Munoz; E Johnson; J Meletiadis; Z-D Pana; M Lackner; P Verweij; T Freiberger; O A Cornely; S Arikan-Akdagli; E Dannaoui; A H Groll; K Lagrou; A Chakrabarti; F Lanternier; L Pagano; A Skiada; M Akova; M C Arendrup; T Boekhout; A Chowdhary; M Cuenca-Estrella; J Guinea; J Guarro; S de Hoog; W Hope; S Kathuria; O Lortholary; J F Meis; A J Ullmann; G Petrikkos; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.